Bioimpedance analysis, metabolic effects and safety of the association Berberis aristata/Bilybum marianum: a 52-week double-blind, placebo-controlled study in obese patients with type 2 diabetes
And I think thats why, to a large extent, you see a really good response. Ozempic and Wegovy do the same thing as GLP-1 would normally do for you but to enable them to treat diabetes and obesity, not just the glucose impact of individual meals, theyve been designed, largely thanks to Knudsens work, with slight changes to allow them to hang out in the blood longer than GLP-1 normally does
Protecting Muscle Is Non-Negotiable Heres what too few clinicians are talking about: GLP-1s, by reducing appetite, can unintentionally reduce protein intake , putting your muscle mass at risk
The back of the middle shelf maintains the most consistent temperature